Skip to main content
. 2023 Jan 19;12:1097816. doi: 10.3389/fonc.2022.1097816

Figure 5.

Figure 5

(A) Confusion matrix for predicting lung cancer relapse in patients based on the FR+-CTC count. (B) Confusion matrix for predicting lung cancer relapse in patients based on the LC. (C) Confusion matrix for predicting lung cancer relapse in patients based on the dNLR. (D) Confusion matrix of the FR+-CTC count combined with the LC to predict lung cancer relapse in patients. (E) Confusion matrix of the FR+-CTC count combined with the dNLR to predict lung cancer relapse in patients. (F) Confusion matrix of the FR+-CTC count combined with the LC and dNLR to predict lung cancer relapse in patients. 0: relapse; 1: no relapse.